DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,370,232 | -13.2% | 1,938,642 | +8.9% | 0.00% | 0.0% |
| Q2 2023 | $20,022,075 | +189.3% | 1,779,740 | +196.2% | 0.00% | – |
| Q1 2023 | $6,921,354 | -48.2% | 600,812 | -47.9% | 0.00% | – |
| Q4 2022 | $13,354,994 | +81.7% | 1,152,286 | +99.1% | 0.00% | – |
| Q3 2022 | $7,352,000 | +91.2% | 578,880 | +3.4% | 0.00% | – |
| Q2 2022 | $3,845,000 | -20.4% | 559,688 | +11.7% | 0.00% | – |
| Q1 2022 | $4,829,000 | -17.5% | 500,971 | +1.8% | 0.00% | – |
| Q4 2021 | $5,854,000 | -25.6% | 492,353 | +1.6% | 0.00% | – |
| Q3 2021 | $7,873,000 | -18.5% | 484,760 | +5.6% | 0.00% | -100.0% |
| Q2 2021 | $9,655,000 | +173.4% | 458,896 | +101.8% | 0.00% | – |
| Q1 2021 | $3,532,000 | -24.2% | 227,404 | +2.4% | 0.00% | – |
| Q4 2020 | $4,662,000 | – | 222,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |